IMD A

IMD A is an investigational topical ointment being evaluated for its wound-healing properties, specifically for the treatment of superficial skin injuries such as forearm abrasions. Developed or tested by HÄLSA Pharma GmbH, the product is typically classified as an investigational medical device (IMD) in European clinical trial contexts. Its efficacy has been studied in healthy volunteers using an abrasive wound model (e.g., trial NCT05483127), where it was compared against other topical formulations and untreated skin. The clinical evaluation of IMD A includes high-resolution skin imaging via Line-field Confocal Optical Coherence Tomography (LC-OCT) to monitor cellular-level healing and a nasal application subpanel to assess local tolerability on mucosal surfaces. While the specific formulation is often proprietary in trial registrations, such products in this clinical context typically utilize active ingredients like dexpanthenol to promote epithelialization and skin barrier restoration.